|
HS Code |
319870 |
| Chemical Name | 1-(4-Bromophenyl)Cyclobutane-1-Carboxynitrile |
| Cas Number | 1193383-09-3 |
| Molecular Formula | C11H10BrN |
| Molecular Weight | 236.11 |
| Appearance | White to off-white solid |
| Melting Point | 101-104°C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Density | 1.45 g/cm³ (approximate) |
| Smiles | N#CC1(c2ccc(Br)cc2)CCC1 |
| Inchi | InChI=1S/C11H10BrN/c12-10-4-2-9(3-5-10)11(7-13)6-1-8-11/h2-5H,1,6,8H2 |
| Purity | Typically >97% |
| Storage Conditions | Store at 2-8°C |
| Synonyms | 4-Bromophenylcyclobutanecarbonitrile |
As an accredited 1-(4-Bromophenyl)Cyclobutane-1-Carboxynitrile factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 1-(4-Bromophenyl)Cyclobutane-1-Carboxynitrile prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry has opened doors for all kinds of industries; from medicines that effortlessly treat pain and infection, to crop-protectors that help farmers feed more people. One molecule making steady ripples in research labs and production floors alike is 1-(4-Bromophenyl)Cyclobutane-1-Carboxynitrile. This name doesn’t roll off the tongue, but chemists spot its structure from a mile away. There’s a reason researchers and industry folks turn to it, even with plenty of other cyclobutanes and brominated compounds on the shelf. In my own lab work, compounds with cyclobutane rings and strategic functional groups always demand respect for their stability and reactivity. The presence of a nitrile group only expands its possibilities. People sometimes forget how small tweaks to a molecule—the difference between a bromine and a chlorine atom, for example—can lead to wildly different properties in the final product or application.
At its core, the compound offers a cyclobutane skeleton—a four-membered ring that’s not as common in large-scale chemical supply as six-membered rings. That little ring brings both tension and opportunity, as the bond angles aren't as relaxed. A chemist once told me during a project: “Cyclobutanes don’t like to sit quietly.” The 4-bromophenyl substituent—essentially, a benzene ring carrying a bromine at the para position—adds both heft and unique electronic effects. Attach a carboxynitrile across that same cyclobutane, and you have a platform to tune both physical and chemical properties for specialized needs.
Many fine chemicals offer flexible building blocks, but this one brings certain unique handles. The bromine atom provides a spot for cross-coupling reactions, so synthetic chemists working on creating more complex molecules (such as pharmaceutical intermediates or advanced agrochemicals) view this structure with interest. The nitrile group attached to the cyclobutane offers a classic route for further transformation—hydrolysis gets you carboxylic acids, reduction leads you to amines, among other routes. Compared to simpler structures, 1-(4-Bromophenyl)Cyclobutane-1-Carboxynitrile let’s you branch out with fewer steps, making synthetic work more streamlined.
Most chemists look for a few core factors: purity, physical appearance, solubility, and stability. This compound, supplied as a white to off-white powder, passes basic inspections for large projects and academic work. Purity, usually running north of 98 percent based on HPLC validation, matters more than most think. I’ve run reactions with sub-par materials and watched yields tumble. Contaminants always create headaches, not only in the flask but down the line during analysis. This compound holds up well during storage at room temperature—nitrile and aryl bromide functionalities aren’t easily knocked off by air or moisture compared to other, fussier molecules.
Solubility counts for both routine work and scale-up. Here, 1-(4-Bromophenyl)Cyclobutane-1-Carboxynitrile dissolves in a range of solvents: a nice touch when you bounce from DMF and DMSO in tiny reactions, to toluene or ethyl acetate during purifications. I’ve found this especially helpful while adjusting reaction conditions—switching solvents doesn’t always mean tweaking the whole recipe. There aren’t nasty odors or volatile hazards with proper care, so routine handling rarely involves elaborate PPE beyond the usual gloves and goggles.
Many organic chemists are listening for two things: “how stable” and “how reactive”. The nitrile group brings a strongly polar, electron-withdrawing flavor—great for improving molecular recognition in medicinal chemistry. The bromine, on the aromatic ring’s para position, turns the compound into a trusted candidate for Suzuki, Heck, or Sonogashira couplings. Palladium catalysts see a bromide as friendly real estate, making it easier to swap in diverse functional groups. In my years in multi-step organic synthesis, para-brominated aromatics usually win out over other halides in cross-coupling efficiency.
This combination—nitrile and bromo—doesn't drop into your lap every day. For a medicinal chemist, both groups matter: the bromine helps build molecular complexity, and the nitrile fine-tunes binding or metabolic properties. Agrochemical researchers use nitriles to develop molecules with soil stability and specific bioactivity. I once watched a screening effort that swapped in a brominated cyclobutane nitrile into a crop-protector scaffold, and the resulting candidate outperformed earlier versions by holding off degradation in harsh field conditions.
The majority of requests come from researchers trying to start with an advanced building block that performs well under diverse reaction conditions. In medicinal chemistry, there’s always a demand for unusual ring systems, and cyclobutanes see attention as bioisosteres—replacements for more common rings that alter biological activity. That’s not just theoretical. Major pharmaceutical companies hunt for analogs with unique 3D shapes, hoping to slip past metabolic enzymes that degrade drug candidates too quickly.
This one plays well in a modular synthesis. The presence of both bromine and nitrile allows synthetic teams to rapidly introduce or swap pieces of the molecule, often using routine palladium-catalysis or other standard transformations. In my group, we’ve slotted it as a middle-step intermediate in making kinase inhibitors; there, the carboxynitrile can be converted to an amide or secondary amine, and the bromine acts as a placeholder for different aryl or alkyl groups. It’s not limited to pharmaceuticals—the agrochemical sector often needs molecules that balance stability with “tunability,” and both functionalities enable smart diversifications of lead compounds.
Some might think all cyclobutane derivatives do the same work, but structural subtleties have major consequences. Cyclobutane rings, four carbons arranged in a square, are already under strain compared to six-membered aromatic rings—making them more willing to engage in certain reactions, and less likely to fall apart under normal conditions. It’s rare to see nitro or amino groups directly on cyclobutane, since those combinations fight each other’s chemistry. Nitrile substitutions, though, sit comfortably and offer chemists a launchpad for downstream transformations.
Comparing 1-(4-Bromophenyl)Cyclobutane-1-Carboxynitrile to something like 1-(4-Chlorophenyl)Cyclobutane-1-Carboxylic Acid, there’s an immediate difference in both reactivity and cost. Bromides transact more easily in cross-coupling; acids, while great for hydrogen-bonding properties, often require more protection-deprotection steps during multi-step synthesis. Nitrile groups, by contrast, don’t complicate purification or introduce water-solubility issues until you want them to. The source of the aryl ring matters, too—switching to a 3-bromophenyl or a 4-fluorophenyl ring can change downstream applications, as electronic patterns shift and molecular geometry alters.
Supply chain issues and inconsistent purity have always haunted both academic and industrial laboratories. I recall delays as we waited for a vital intermediate, only to discover it arrived at 93 percent purity when the data sheet claimed above 99. Those six points spelled extra purification, lost time, and knocked out half our planned experiments. With 1-(4-Bromophenyl)Cyclobutane-1-Carboxynitrile, most reputable suppliers provide detailed HPLC traces, NMR spectra, and melting point data. That full paperwork keeps setbacks to a minimum. You buy with peace of mind if you see full supporting data.
This isn’t just about data, but reliability in the field. Anyone can slap an impressive certificate of analysis onto a product, but consistent batches across years and projects cement a supplier’s reputation. Customers often return for this compound because batches show narrow melting-point ranges and consistent spectral data—both signs of clean, careful synthetic work. My own bias tilts toward suppliers who test every new lot, not just the first batch they ship, and that practice becomes especially important during scale-up or regulatory submissions.
Emerging research always seeks new building blocks that don’t just replicate old work in a new wrapper. Here, the fusion of a cyclobutane and an aryl bromide, plus a conveniently placed nitrile, appeals to forward-thinking chemists. More groups invest in cycloalkyl scaffolds by the year, hoping to break free from the “flatland” of planar molecules that chew up most patents and research dollars. The push for patent diversity, new modes of action, and products that resist resistance—be it in bacteria or crop pests—relies heavily on unique core structures.
Several patent documents from both pharmaceutical and agrochemical companies reference cyclobutane analogs substituted with different aryl groups and electron-withdrawing substituents. In one case, a global pharma firm described new kinase inhibitors where the cyclobutane replaced common aromatic rings, and a nitrile at the 1-position improved potency against resistant cancer cell lines. As a bonus, molecules like 1-(4-Bromophenyl)Cyclobutane-1-Carboxynitrile offer enough rigidity to lock a bioactive conformation, yet avoid metabolism by common enzymes—a prized trait for both drugs and crop-protectors.
No chemical stands apart from the broader supply landscape. Sourcing reliable intermediates, particularly ones with halogens, sometimes faces hiccups around regulatory controls. For years, brominated aromatics enjoyed smoother trips across borders, but international treaties now scrutinize halogenated chemicals more closely. Several facilities in Asia, especially China and India, provide bulk manufacturing, but disruptions in these regions can spike costs or squeeze availability.
Disposal is a real-world issue. While 1-(4-Bromophenyl)Cyclobutane-1-Carboxynitrile itself doesn’t create the environmental headaches of perfluorinated compounds or heavy metals, labs and factories using it still need plans for bromide-rich waste. My advice: prioritize solvent recovery, use bromine scavengers when you can, and opt for closed systems to catch fugitive emissions. Modern fine-chem manufacturers—with tighter regulatory expectations—have made it easier to maintain responsible waste practices while still delivering the high-purity product chemists require.
Researchers looking to make the most of 1-(4-Bromophenyl)Cyclobutane-1-Carboxynitrile should demand more than just high purity. Ask suppliers for full documentation with every batch: chromatograms, spectral data, and storage guidelines. That transparency shields you from interrupted workflows and unexpected setbacks. Where possible, use small-scale pilot reactions before scaling; the unique structure sometimes calls for adjustments to temperature, base, or reaction partners compared to more common aromatics.
For producers, the challenge remains one of consistency and efficiency. Batch-to-batch variation kills productivity downstream, where even small impurities can translate to failed regulatory filings or costly rework. Upstream, stick with validated processes: don’t chase marginal cost savings by switching sources of raw materials. In my experience, “cheaper” starting materials tempt manufacturers but rarely pay off if product quality drops and customers move on.
Environmental compliance should be a factory’s standard. Solvent recycling, capture of halogen waste, and secondary waste treatment help maintain good standing with regulatory authorities while protecting nearby communities. Share best practices across sites—even minor upgrades to reactors, filtration systems, or ventilation can reduce both cost and environmental footprint.
In the next decade, synthetic chemistry will only get more creative. Planning for success means having access to rare, functionally rich building blocks like 1-(4-Bromophenyl)Cyclobutane-1-Carboxynitrile. Whether in drug discovery, new pesticide formulation, or material science, this molecule offers multiple entry points for research and innovation. Trends point toward increased demand for structures that break from traditional, flat aromatics; anyone working in late-stage discovery recognizes the value of introducing 3D shape and controlled reactivity.
Institutes and industrial R&D teams who prioritize novel cyclobutane scaffolds widen their potential for breakthroughs, whether by creating new intellectual property or overcoming hurdles in bioavailability and target selectivity. The unique mix of bromine and nitrile on a cyclobutane ring doesn’t just fill a catalog slot—it invites fresh approaches to long-standing problems. With a track record of reliability, reactivity, and compatibility with modern synthetic techniques, this compound carves out a strong niche, and will likely see continued attention for years to come.